Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 19 tags : Disease save search
Zynerba Pharmaceuticals Announces Presentation of Poster at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit
Published: 2021-10-19 (Crawled : 21:00) - zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.0%
H: 1.0%
C: 0.0%
presentation disease rare
MyMD Pharmaceuticals to Discuss its Novel Therapies for Aging and Related Diseases at the Dawson James Securities 6th Annual Small Cap Growth Conference on October 21
Published: 2021-10-19 (Crawled : 19:00) - biospace.com/
MYMD | $2.86 11.72% 12.33% 100K
|
Manufacturing
|
| O: 3.81%
H: 4.94%
C: 2.64%
disease growth conference
Global Infectious Disease Diagnostics Market to Reach $20.1 Billion by 2026
Published: 2021-10-19 (Crawled : 15:00) - prnewswire.com
DHR | $250.41 -1.07% -0.46% 2.3M
|
Health Technology
|
| O: 0.7%
H: 1.34%
C: 0.71%
BIO | $278.21 -2.48% 0.0% 210K
|
Health Technology
|
| O: 0.71%
H: 1.03%
C: 0.05%
BDX | $233.83 -0.23% 0.0% 6
|
Health Technology
|
| O: 0.44%
H: 1.44%
C: 1.35%
ABT | News | $106.89 -0.65% -0.09% 4.2M
|
Health Technology
|
| O: 0.21%
H: 2.67%
C: 1.95%
QDEL | News 4 | $40.82 1.04% 1.0% 950K
|
Health Technology
|
| O: 1.45%
H: 2.98%
C: 0.74%
disease infectious disease diagnostics diagnostic
Cyclo Therapeutics Recognizes Niemann-Pick Disease Awareness Month Highlighting Need for Broader Awareness and Support for Research to Find a Treatment
Published: 2021-10-19 (Crawled : 15:00) - biospace.com/
CYTH | $1.3 7.44% 7.94% 21K
|
Professional, Scientific, and T...
|
| O: -0.13%
H: 3.78%
C: 0.44%
disease treatment ema research
MeiraGTx Announces the Presentation of Two Novel Inherited Retinal Disease (IRD) Programs and Riboswitch Gene Regulation Platform at the European Society of Gene and Cell Therapy (ESGCT) 2021 Annual Congress
Published: 2021-10-19 (Crawled : 14:00) - globenewswire.com
MGTX | $4.86 -1.42% -1.23% 110K
|
Health Technology
|
| O: -0.11%
H: 10.03%
C: 2.75%
presentation disease europe therapy retina
ImmunityBio Announces Primary Endpoint Met in a Second Indication in Bladder Cancer Trial with 57% Disease-Free Survival in Patients with BCG Unresponsive Papillary Disease
Published: 2021-10-19 (Crawled : 13:15) - nantkwest.com
IBRX | $4.82 -12.2% -14.02% 7.4M
|
Manufacturing
|
| O: 0.9%
H: 2.89%
C: 1.78%
disease bladder cancer cancer trial bladder
AVROBIO Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1
Published: 2021-10-19 (Crawled : 12:00) - biospace.com/
AVRO | $1.19 -1.65% -1.26% 350K
|
Health Technology
|
| O: 0.54%
H: 3.66%
C: 1.25%
disease gene therapies gene therapy therapy
ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference
Published: 2021-10-19 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.46 -1.22% -1.16% 1.3M
|
Health Technology
|
| O: 0.91%
H: 1.8%
C: 0.0%
presentation disease respiratory influenza conference
Beam Therapeutics Announces Preclinical Data Highlighting Base Editing Approach to Correct a Glycogen Storage Disease Type Ia Disease-Causing Mutation
Published: 2021-10-19 (Crawled : 11:00) - globenewswire.com
BEAM | $22.74 -3.11% -3.21% 130
|
Health Technology
|
| O: 2.35%
H: 3.8%
C: 1.63%
disease preclinical pre-clinical
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.